Orthopedic Biomaerials Market Analysis, Size, Trends | South Korea | MedSuite
Bone graft substitutes are designed to fill bone voids, which eliminates the need for autograft harvesting of the patients own bone. Viscosupplementation products are injected directly into the affected knee joint to relieve pain caused by osteoarthritis. Growth factors are naturally occurring molecules in the body that mediate various cellular functions.
- Year: 2016
- Scope: 2016-2026
- Region: South Korea
- Published Date: 02/04/2020
- Pages: 274
- Type: MedSuite
Surgical procedures that require the use of orthopedic biomaterials are generally associated with diseases and indications that become more prevalent in the population with an increase in age, such as osteoarthritis of the spine and knee. In 2019, approximately 15% of South Koreans were aged 65 and over; this proportion is projected to grow steadily over the forecast period, as further cohorts of baby boomers turn 65. Growth of this population is expected to stimulate growth across all segments of the orthopedic biomaterials market.
While this report suite contains all data, each of the markets are also available as stand alone MedCore reports. This allows you to get access to only the market research that you need. You can view all these included reports and segmentation here:
- Procedure Numbers for Orthobiologics – MedPro: Using a number of databases, internal and external, we’re able to provide you with the total volume of orthopedic biomaterials procedures being performed for each of the markets mentioned in this suite of reports.
- Bone Graft Substitutes Market – MedCore: Bone is a biologically active tissue and will regenerate whenever possible; however, there are instances where the damage is significant enough to warrant a scaffold to help rejoin the fissure or cavity. Bone grafting is a surgical procedure in which damaged bone is replaced with autograft tissue, allograft tissue or a bone graft substitute, which can be either synthetic or metal.
- Hyaluronic Acid Viscosupplementation Market – MedCore: Hyaluronic acids (HAs) are naturally occurring biopolymer fluids found in the joints that help cushion them from wear. Sufferers of osteoarthritis are deficient in these fluids. First proposed by Balazs in 1993, viscosupplementation with intraarticular hyaluronic acid (HA) injections have emerged as a viable treatment modality for nonoperative care of symptomatic osteoarthritis. Viscosupplements are injectable products that come in three varieties of injection regimens: single-injection, three-injection amd five-injection HA cycles.
Report Data Types Included
- Unit Sales, Average Selling Prices, Market Value & Growth Trends
- Forecasts Until 2026, and Historical Data to 2016
- Market Drivers & Limiters for Each Segment
- Competitive Analysis with Market Shares for Each Segment
- Recent Mergers & Acquisitions
- Procedure Volumes
- Disease Overviews and Demographic Information
- Company Profiles, Product Portfolios for Top Competitors
- Related Press Releases from Top Competitors
Orthobiologics Market Share Insights
In 2019, the leading competitor in the South Korean orthopedic biomaterials market was Cellumed, which was attributed to its leading position in the orthopedic bone graft substitute market. The company held the second-leading position in the allograft and DBM allograft markets. Cellumed’s portfolio includes an allograft product line and the Rafugen™ DBM allograft product line.
EXECUTIVE SUMMARY 1SOUTH KOREAN ORTHOPEDIC BIOMATERIALS MARKET OVERVIEW 1COMPETITIVE ANALYSIS 3MARKET TRENDS 5MARKET DEVELOPMENTS 6PROCEDURE NUMBERS 7MARKETS INCLUDED 8KEY REPORT UPDATES 10VERSION HISTORY 10
RESEARCH METHODOLOGY 11Step 1: Project Initiation & Team Selection 11Step 2: Prepare Data Systems and Perform Secondary Research 14Step 3: Preparation for Interviews & Questionnaire Design 16Step 4: Performing Primary Research 17Step 5: Research Analysis: Establishing Baseline Estimates 19Step 6: Market Forecast and Analysis 20Step 7: Identify Strategic Opportunities 22Step 8: Final Review and Market Release 23Step 9: Customer Feedback and Market Monitoring 24
PRODUCT ASSESSMENT 252.1 INTRODUCTION 252.2 PRODUCT PORTFOLIOS 252.2.1 Bone Graft Substitutes 262.2.2 Growth Factors 3188.8.131.52 Other Products 352.2.3 Hyaluronic Acid Viscosupplementation (HAV) 372.3 REGULATORY ISSUES AND RECALLS 402.3.1 Bone Graft Substitutes 402.3.1.1 Allografts 402.3.1.1.1 MTF 402.3.1.2 DBM 402.3.1.2.1 AlloSource 402.3.1.2.2 SeaSpine 4184.108.40.206.3 RTI Surgical 4220.127.116.11 Synthetics 418.104.22.168.1 Abyrx 422.214.171.124.2 Zimmer Biomet 422.3.2 Growth Factors 4126.96.36.199.1 Medtronic 422.3.3 Hyaluronic Acid Viscosupplementation 4188.8.131.52 Three-injection 4184.108.40.206.1 Ferring Pharmaceuticals 432.4 CLINICAL TRIALS 442.4.1 Bone Graft Substitutes 4220.127.116.11 Allografts 418.104.22.168.1 Providence Medical Technology 422.214.171.124.2 The University of Texas Health Science 4126.96.36.199.3 University of Winchester 4188.8.131.52 BDM 4184.108.40.206.1 K2M 4220.127.116.11.2 Zimmer Biomet 418.104.22.168 Synthetics 422.214.171.124.1 Baxter 4126.96.36.199.2 Bonesupport 4188.8.131.52.3 DePuy Synthes 4184.108.40.206.4 NuVasive 4220.127.116.11.5 RTI surgical 418.104.22.168.6 Sunstar GUIDOR 502.4.1.4 Other materials and comparison 522.214.171.124.1 Seoul National University Hospital. 5126.96.36.199.2 Sewon Cellontech 5188.8.131.52.3 SurgaColl Technologies Limited 5184.108.40.206.4 University of Colorado 5220.127.116.11.5 University of Padova 532.4.2 Growth Factors 518.104.22.168.1 Bioventus 522.214.171.124.2 Cerapedics 5126.96.36.199.3 CGBio 5188.8.131.52.4 Isto 5184.108.40.206.5 Medtronic 5220.127.116.11.6 NuVasive 518.104.22.168.7 Wright 522.214.171.124.8 Others 582.4.3 Hyaluronic Acid Viscosupplementation 5126.96.36.199.1 Anika Therapeutics 5188.8.131.52.2 Bioventus 602.4.3.1.3 Cairo University 6184.108.40.206.4 Ferring Pharmaceuticals 6220.127.116.11.5 Federal University of Minas Gerais 618.104.22.168.6 Fidia Pharma USA Inc. 622.214.171.124.7 Istituto Ortopedico Rizzoli 6126.96.36.199.8 University Hospital 6188.8.131.52.9 Universidade Nova de Lisboa 64
SOUTH KOREAN ORTHOPEDIC BIOMATERIALS MARKET OVERVIEW 653.1 INTRODUCTION 653.1.1 Bone Graft Substitutes 653.1.2 Growth Factors 653.1.3 Hyaluronic Acid (HA) Viscosupplementation 663.2 CURRENCY EXCHANGE RATE 673.3 MARKET OVERVIEW AND TREND ANALYSIS 683.4 DRIVERS AND LIMITERS 753.4.1 Market Drivers 753.4.2 Market Limiters 753.5 COMPETITIVE MARKET SHARE ANALYSIS 773.6 MERGERS AND ACQUISITIONS 823.7 COMPANY PROFILES 843.7.1 Anika Therapeutics 843.7.2 Bioventus 853.7.3 DePuy Synthes 863.7.4 Ferring Pharmaceuticals 873.7.5 Fidia Pharmaceuticals 883.7.6 Genzyme (Sanofi Group) 893.7.7 Harvest Technologies (Terumo BCT) 903.7.8 Integra LifeSciences 913.7.9 Medtronic 923.7.10 Musculoskeletal Transplant Foundation (MTF) 943.7.11 NuVasive 953.7.12 Orthofix 963.7.13 RTI Surgical 973.7.14 Stryker 983.7.15 Vericel Corporation (formerly Aastrom Bioscience) 993.7.16 Zimmer Biomet 1003.8 SWOT ANALYSIS 1023.8.1 Anika Therapeutics 1023.8.2 Bioventus 1043.8.3 DePuy Synthes 1063.8.4 Ferring Pharmaceuticals 1073.8.5 Fidia Pharmaceuticals 1083.8.7 Harvest Technologies (Terumo BCT) 1103.8.8 Integra LifeSciences 1113.8.9 Medtronic 1123.8.10 Musculoskeletal Transplant Foundation (MTF) 1133.8.11 NuVasive 1143.8.12 Orthofix 1153.8.14 Stryker 1173.8.15 Vericel Corporation (formerly Aastrom Bioscience) 1183.8.16 Zimmer Biomet 119
PROCEDURE NUMBERS 1214.1 INTRODUCTION 1214.2 PROCEDURES 1224.2.1 Orthopedic Biomaterial Procedures by Segment 1224.2.2 Orthopedic Bone Grafting Procedures 1244.2.2.1 Units per Procedure by Indication 1244.2.2.2 Orthopedic Bone Grafting Procedures by Material 1254.2.2.2.1 Autograft Procedures by Indication 12184.108.40.206.2 Allograft Procedures by Indication 1304.2.2.2.3 DBM Procedures by Indication 13220.127.116.11.4 Synthetic Procedures by Indication 1318.104.22.168 Orthopedic Bone Grafting Procedures by Indication 1394.2.3 Hyaluronic Acid Viscosupplementation Procedures 1422.214.171.124 Hyaluronic Acid Viscosupplementation Procedures by Injection Cycle 142
ORTHOPEDIC BONE GRAFT SUBSTITUTE MARKET 1445.1 INTRODUCTION 1445.2 MARKET OVERVIEW 1455.2.1 Orthopedic Bone Graft Substitute Market by Material 1455.2.2 Orthopedic Bone Graft Substitute Market by Indication 1505.3 MARKET ANALYSIS AND FORECAST 1565.3.1 Total Orthopedic Bone Graft Substitute Market 1565.3.2 Orthopedic Bone Graft Substitute Market by Material 15126.96.36.199 Allograft Bone Graft Substitute Market 15188.8.131.52.1 Allograft Bone Graft Substitute Market by Indication 16184.108.40.206 Demineralized Bone Matrix Allograft Bone Graft Substitute Market 17220.127.116.11.1 Demineralized Bone Matrix Allograft Bone Graft Substitute Market by Indication 1718.104.22.168 Synthetic Bone Graft Substitute Market 1922.214.171.124.1 Synthetic Bone Graft Substitute Market by Indication 1955.3.3 Orthopedic Bone Graft Substitute Market by Indication 2095.3.3.1 Spine Bone Graft Substitute Market 2095.3.3.2 Cervical Spine Bone Graft Substitute Market 2126.96.36.199 Thoracolumbar Spine Bone Graft Substitute Market 2188.8.131.52 Trauma Bone Graft Substitute Market 2184.108.40.206 Non-Union Trauma Bone Graft Substitute Market 2220.127.116.11 Fresh Fracture Trauma Bone Graft Substitute Market 218.104.22.168 Large Joint Reconstruction Bone Graft Substitute Market 222.214.171.124 Hip Reconstruction Bone Graft Substitute Market 22126.96.36.199 Knee Reconstruction Bone Graft Substitute Market 22188.8.131.52 Foot Reconstruction Bone Graft Substitute Market 2305.3.3.11 Craniomaxillofacial Bone Graft Substitute Market 23184.108.40.206 Oncology Bone Graft Substitute Market 2365.4 DRIVERS AND LIMITERS 2395.4.1 Market Drivers 2395.4.2 Market Limiters 2395.5 COMPETITIVE MARKET SHARE ANALYSIS 241
HYALURONIC ACID VISCOSUPPLEMENTATION MARKET 2456.1 INTRODUCTION 2456.1.1 Benefits of Viscosupplementation 2466.1.2 Synovial Fluid 2466.2 MARKET OVERVIEW 2476.3 MARKET ANALYSIS AND FORECAST 2536.3.1 Total Hyaluronic Acid Viscosupplementation Market 2536.3.2 Single-Injection Hyaluronic Acid Viscosupplementation Market 2566.3.3 Three-Injection Hyaluronic Acid Viscosupplementation Market 2596.3.4 Five-Injection Hyaluronic Acid Viscosupplementation Market 2626.4 DRIVERS AND LIMITERS 2656.4.1 Market Drivers 2656.4.2 Market Limiters 2656.5 COMPETITIVE MARKET SHARE ANALYSIS 267
APPENDIX: ORTHOPEDIC GROWTH FACTOR MARKET 2717.1 INTRODUCTION 2717.1.1 BMP-2 (Cellumed, CG Bio) 272
All Companies Analyzed in this Study
iData’s 9-Step Research MethodologyOur reports follow an in-depth 9-step methodology which focuses on the following research systems:
- Original primary research that consists of the most up-to-date market data
- Strong foundation of quantitative and qualitative research
- Focused on the needs and strategic challenges of the industry participants
Step 1: Project Initiation & Team Selection During this preliminary investigation, all staff members involved in the industry discusses the topic in detail.
Step 2: Prepare Data Systems and Perform Secondary Research The first task of the research team is to prepare for the data collection process: Filing systems and relational databases are developed as needed.
Step 3: Preparation for Interviews & Questionnaire Design The core of all iData research reports is primary market research. Interviews with industry insiders represent the single most reliable way to obtain accurate, current data about market conditions, trends, threats and opportunities.
Step 4: Performing Primary Research At this stage, interviews are performed using contacts and information acquired in the secondary research phase.
Step 5: Research Analysis: Establishing Baseline Estimates Following the completion of the primary research phase, the collected information must be synthesized into an accurate view of the market status. The most important question is the current state of the market.
Step 6: Market Forecast and Analysis iData Research uses a proprietary method to combine statistical data and opinions of industry experts to forecast future market values.
Step 7: Identify Strategic Opportunities iData analysts identify in broad terms why some companies are gaining or losing share within a given market segment.
Step 8: Final Review and Market Release An integral part of the iData research methodology is a built-in philosophy of quality control and continuing improvement is integral to the iData philosophy.
Step 9: Customer Feedback and Market Monitoring iData philosophy of continuous improvement requires that reports and consulting projects be monitored after release for customer feedback and market accuracy.